(Q47637698)

4 February 2018

title

Molecular mechanism of violacein-mediated human leukemia cell death (English)

1 reference

4 February 2018

Chromobacterium violaceum

1 reference

1 reference

1 reference

1 reference

1 reference

3

1 reference

4 February 2018

Maikel P Peppelenbosch

object named as

Maikel P Peppelenbosch

6

0 references

Nelson Durán

object named as

Nelson Durán

Carmen Veríssima Ferreira Halder

5

0 references

0 references

author name string

Carmen Veríssima Ferreira

1

1 reference

4 February 2018

Carina L Bos

2

1 reference

4 February 2018

Giselle Z Justo

4

1 reference

4 February 2018

language of work or name

English

0 references

publication date

6 May 2004

1 reference

4 February 2018

full work available at URL

https://ashpublications.org/blood/article-pdf/104/5/1459/1700940/zh801704001459.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1182/blood-2004-02-0594?email=unpaywall_01@example.com

published in

Blood

1 reference

4 February 2018

volume

104

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

page(s)

1459-1464

1 reference

4 February 2018

https://api.unpaywall.org/v2/10.1182/blood-2004-02-0594?email=unpaywall_01@example.com

1 reference

19 March 2024

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/IJC.2910170504

K562—A human erythroleukemic cell line

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Violacein and its beta-cyclodextrin complexes induce apoptosis and differentiation in HL60 cells.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Chromobacterium violaceum: a review of pharmacological and industiral perspectives

0 references

Determination of protein: A modification of the lowry method that gives a linear photometric response

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Apoptosis and cancer chemotherapy

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Molecular signals in anti-apoptotic survival pathways.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Evaluation of the antiulcerogenic activity of violacein and its modulation by the inclusion complexation with beta-cyclodextrin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Antileishmanial activity of the violacein extracted from Chromobacterium violaceum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Cytotoxic effect of the diterpene lactone dehydrocrotonin from Croton cajucara on human promyelocytic leukemia cells.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

NF-kappaB at the crossroads of life and death

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2004-02-0594

Identifiers

DOI

10.1182/BLOOD-2004-02-0594

1 reference

4 February 2018

1 reference

4 February 2018